Central Nervous System Agents for Ischemic Stroke: Neuroprotection Mechanisms

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 81-97

Bentham Science Publishers

Access to resources Recommend Favorite

Neurogenesis and Stroke

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 5, 2007-10 ,pp. : 321-325

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury

By  

Current Neuropharmacology, Vol. 8, Iss. 4, 2010-12 ,pp. : 324-334

Bentham Science Publishers

Access to resources Recommend Favorite

Albumin Induces Neuroprotection Against Ischemic Stroke by Altering Toll-Like Receptor 4 and Regulatory T Cells in Mice

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 2, 2013-04 ,pp. : 220-227

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Neuroprotection and Neuroregeneration in Ischemic Stroke: Emerging Treatment Strategies and Potential Molecular Targets)

By  

Current Drug Targets, Vol. 14, Iss. 1, 2013-01 ,pp. : 1-2

Bentham Science Publishers

Access to resources Recommend Favorite